I call this meeting to order.
Welcome to meeting number 60 of the House of Commons Standing Committee on Health. Today we will consider Bill C-252, before proceeding to drafting instructions for the report on children's health and to committee business, in camera.
I'd like to, first of all, indicate to the committee that, in accordance with our routine motion—and as you know first-hand—all remote participants have completed the required connection tests in advance of the meeting.
I will now welcome back Ms. Lattanzio, the sponsor of Bill C-252, and our two officials from Health Canada. Thank you for coming back to be with us.
They are here, of course, in case there are questions for the department about the bill. They are Dr. Supriya Sharma, chief medical adviser and senior medical adviser, health products and food branch; and David Lee, chief regulatory officer, health products and food branch.
(On clause 4)
When we left off on Tuesday, we were discussing amendment G-2, which is an amendment to clause 4, so I would suggest that we pick up where we left off.
I recognize Mrs. Goodridge.